TobaccoReporter logo

Tag: cigarettes

  • Companies to Post ‘Corrective Statements’

    Companies to Post ‘Corrective Statements’

    Image: Wirestock | Adobe Stock

    Tobacco companies will have to start displaying signs with “corrective” statements about the health effects and addictive nature of cigarettes at U.S. points of sale in the second half of 2023, according to the Department of Justice (DOJ), reports Fox News. A court order requiring the statements will take effect July 1, 2023, after which tobacco companies will have three months to start posting the statements for 21 months in English and Spanish.

    The order “resolves the government’s long-running civil racketeering lawsuit against the largest United States cigarette companies,” according to the DOJ. The racketeering lawsuit was filed in 1999 and ended in 2005; however, the DOJ said the new court order is the last of several corrective remedies related to that case.

    Altria Group, Philip Morris USA, R.J. Reynolds Tobacco Co. and four cigarette brands owned by ITG Brands are subject to the order. An estimated 200,000 of 300,000 retail stores in the U.S. that sell cigarettes have agreements with the tobacco companies. The order requires the companies to amend their agreements, requiring corrective statements to be placed at the stores on color signs that are eye-catching. Messaging will include adverse health effects of smoking, the addictive nature of nicotine and adverse health effects of secondhand smoke, among others.

    “Justice Department attorneys have worked diligently for over 20 years to hold accountable the tobacco companies that defrauded consumers about the health risks of smoking,” said Associate Attorney General Vanita Gupta. “Today’s resolution implements the last remedy of this litigation to ensure that consumers know the true dangers of the smoking products they may consider purchasing.”

    “This is an important moment in the history of cancer control in the United States,” said William Klein, associate director of the National Cancer Institute’s behavioral research program. “Smoking causes about 30 percent of all cancer deaths in the United States, and therefore, the court-ordered corrective statements appearing at the point of cigarette sale will help support our mission to reduce the burden of cancer. We are grateful to our colleagues at the Department of Justice for having completed this significant work.”

  • FDA Ignored Evidence in ‘Deeming’ Premium Cigars

    FDA Ignored Evidence in ‘Deeming’ Premium Cigars

    Photo: Viacheslav Yakobchuk

    The U.S. Food and Drug Administration ignored evidence about health risks in considering premium cigars to be subject to same law as cigarettes, a federal judge ruled on July 5, reports Reuters.  

    The litigation focuses on the 2016 Deeming Rule, in which the agency identified a wide range of tobacco products, including premium cigars, to be subject to its regulatory authority along with cigarettes under the Family Smoking Prevention and Tobacco Control Act.

    The FDA rule requires cigar makers to register their products annually, provide ingredient lists for each product and submit products for laboratory testing—procedures the premium cigar industry considers impractical for its handmade, “artisan” products.

    The Premium Cigar Association and Cigar Rights of America challenged the Deeming Rule, arguing that, unlike cigarettes and e-cigarettes, premium cigars do not appeal to young people and are not associated with addiction. They cited studies showing that young people are unlikely to use premium cigars, that users of premium cigars are unlikely to smoke them frequently and that infrequent cigar use is not associated with increased mortality.

    U.S. District Judge Amit Mehta in Washington DC agreed that the FDA had not adequately considered the studies cited by the plaintiffs, instead asserting that there was “no evidence” that premium cigars were less harmful.

    “Where, as here, an agency speaks in absolute terms that there is no evidence, it acts arbitrarily and capriciously when there is in fact pertinent record evidence and the agency ignores or overlooks it,” the judge wrote.

    Judge Mehta asked the FDA and the industry groups to submit briefs on whether he should vacate the FDA’s decision or simply remand the matter back to the agency.

  • Study: Vapes Have Higher Health Costs Than Smokes

    Study: Vapes Have Higher Health Costs Than Smokes

    Photo: Tobacco Reporter Archive

    The use of electronic cigarettes costs the United States $15 billion annually in healthcare expenditures—more than $2,000 per person a year—according to a study by researchers at the University of California San Francisco School of Nursing.

    The study, published on May 23 in Tobacco Control, is the first to look at the healthcare costs of e-cigarette use among adults 18 and older, according to the release.

    “Our finding indicates that healthcare expenditures for a person who uses e-cigarettes are $2,024 more per year than for a person who doesn’t use any tobacco products,” said lead author Yingning Wang of the UCSF Institute for Health and Aging.

    According to the U.S. Centers for Disease Control and Prevention, combustible cigarette smoking-related illness in the United States costs more than $300 billion each year, including more than $225 billion for direct medical care for adults.

    The researchers based their estimates of healthcare costs and utilization on data from the 2015–2018 National Health Interview Survey. Healthcare utilization included nights in the hospital, emergency room visits, doctor visits and home visits.

    “Healthcare costs attributable to e-cigarette use are already greater than our estimates of healthcare costs attributable to cigar and smokeless tobacco use,” said Wang. “This is a concerning finding given that e-cigarettes are a relatively new product whose impact is likely to increase over time.”

  • Rising Oil Prices May Affect Cigarette Sales

    Rising Oil Prices May Affect Cigarette Sales

    Photo: Destina | Adobe Stock

    Rising gas prices will likely depress cigarette demand due to consumers having less cash to spend at gas stations, according to CNBC.

    The Russian invasion of Ukraine has driven oil prices up as the U.S. and other Western countries have imposed sanctions on Russia. On Thursday, West Texas Intermediate crude futures, the U.S. oil benchmark, was trading at prices not seen since the financial crisis of September 2008, and Brent crude hit a high from May 2012.

    Gaurav Jain, a Barclays analyst, estimates that a 1 percent increase in oil prices will cause U.S. cigarette volume to decline by 0.1 percent. “The trend seems to suggest that as consumers saved more money at the gas station and went to the attached convenience store, they bought more cigarettes (impulse purchase item). Now as oil prices move higher, the reverse could happen,” Jain wrote in a note to clients.

    Jain predicts that U.S. cigarette volume for fiscal 2022 will fall by 5 percent with prices rising 7 percent. It’s also expected that some consumers will switch to other tobacco products, such as e-cigarettes or modern oral nicotine pouches, in search of cheaper alternatives.